DexCom
$69.96
24H
Market Cap
Volume
Supply
Price Chart
About DexCom - DXCM
DexCom, Inc. is a company that specializes in the design and development of continuous glucose monitoring systems for diabetes management. Their technology allows patients to track their blood sugar levels in real-time without the need for traditional fingerstick testing.
What are DexCom's core values and mission statement?
DexCom, Inc., a company specializing in continuous glucose monitoring, is driven by values that emphasize patient focus, innovation, accountability, integrity, and teamwork. Their mission statement revolves around empowering people to take control of diabetes through continuous glucose monitoring technology and exceptional patient service.
Who founded DexCom and when?
DexCom, Inc. was founded in 1999 by John Burd, along with Jake Leach, Andrew Rasdal, George Caulkins, and Terrance Gregg.
Who leads DexCom?
As of the latest publicly available information, DexCom, Inc. is led by Kevin Sayer, who serves as the company’s President and Chief Executive Officer.
Where is DexCom located, and what is its base country?
DexCom, Inc. is headquartered in San Diego, California, United States. Its base country is the United States.
On which exchanges is DexCom traded?
DexCom, Inc. is traded on the NASDAQ Stock Market under the ticker symbol DXCM.
Historical data
DexCom (DXCM) Price Live Data
The live price of DexCom (DXCM) is $69.96, with a trading volume of 3,019,905 in the last 24 hours. Wrapstocks updates the DXCM price in real-time. DexCom is up 1.52% in the last 24 hours. The company has a live market cap of $27,326,025,728.00 and a supply of 390,594,993 DXCM stocks.
DexCom (DXCM) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 2 hours and 33 minutes.